Page last updated: 2024-08-16

temozolomide and lumefantrine

temozolomide has been researched along with lumefantrine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Banerjee, I; Biswas, A; Cavenee, WK; Das, S; Das, SK; Emdad, L; Fisher, PB; Kumar, U; Maji, S; Mandal, M; Rajesh, Y	1

Other Studies

1 other study(ies) available for temozolomide and lumefantrine

Article	Year
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-02, Volume: 117, Issue:22 Topics: Antimalarials; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glioblastoma; Heat-Shock Proteins; Humans; Lumefantrine; Microfilament Proteins; Molecular Chaperones; Temozolomide; Trans-Activators	2020

Article

Year

Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.

Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-02, Volume: 117, Issue:22

Topics: Antimalarials; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glioblastoma; Heat-Shock Proteins; Humans; Lumefantrine; Microfilament Proteins; Molecular Chaperones; Temozolomide; Trans-Activators

2020